Oxford Science Enterprises is an independent investment company that finds, funds, and builds transformational science and technology companies emerging from Oxford research.
Portfolio
25
companies
AUM
£1.0B
under management
Allos
Allos applies causal artificial intelligence to reformulate complex generic drugs and improve patient medicines.
Archangel Lightworks
Archangel Lightworks builds laser communications infrastructure to connect space networks with the ground.
Brill Power
Brill Power develops intelligent battery management systems to improve energy storage and vehicle performance.
Caristo Diagnostics
Caristo Diagnostics develops AI-assisted tools for cardiac and vascular disease diagnostics.
FluoRok
FluoRok develops sustainable technologies for manufacturing fluorochemicals.
Fractile
Fractile builds high performance artificial intelligence hardware and software for faster and cheaper inference workloads.
Kneu Health
A precision neurology platform for tracking Parkinson and dementia via smartphones.
Mixergy
Smart hot water storage and home energy solutions provider.
MoA Technology
MoA Technology develops next-generation herbicides to combat global weed resistance.
Natcap
Natcap delivers nature intelligence technology that helps businesses measure and report ecological risks.
Navenio
Navenio provides indoor location technology and task allocation software to improve healthcare workflow efficiency.
Neu Health
Neu Health builds a digital care platform for neurology patients.
ONI
ONI develops desktop super-resolution microscopes for cellular and molecular research.
ORCA Computing
ORCA Computing develops full-stack photonic quantum computing systems.
Osler Diagnostics
Osler Diagnostics develops portable tabletop blood-testing devices for clinical and decentralized settings.
Oxford Endovascular
Oxford Endovascular develops origami-inspired medical devices for brain aneurysm treatment.
Oxford Ionics
Oxford Ionics builds high-performance quantum computers using trapped-ion technology.
Oxford Quantum Circuits
Oxford Quantum Circuits develops advanced quantum computing hardware using patented 3D architecture.
PQShield
PQShield builds quantum-resistant cryptographic solutions for the global technology supply chain.
Prolific
Prolific provides human data and research infrastructure to train and refine artificial intelligence models.
Quantum Motion
Quantum Motion builds silicon transistor-based quantum computers designed for standard data-centre racks.
Salience Labs
Salience Labs builds ultra high-speed multi-chip processors that combine photonics and electronics for artificial intelligence applications.
Stateful Robotics
Stateful Robotics develops decision intelligence software to help mobile robots operate reliably in unpredictable environments.
Ultromics
Ultromics develops artificial intelligence tools to detect hidden heart disease.
Wild Bioscience
Wild Bioscience develops climate-resilient crop varieties using evolutionary biology and artificial intelligence.
Alexis Zervoglos
Partner
Alexis brings investment and board experience from Oxford Science Enterprises and Science Capital. He previously founded Arborescent.
LinkedInWill Goodlad
Sam Harman
Head of Deep Tech
Sam is a partner and head of deep tech at Oxford Science Enterprises. He also holds board positions at several companies, including Prolific, Fractile, and Archangel Lightworks.
LinkedInHeather Roxborough
senior partner of Health Tech
Nick Dixon-Clegg
Partner
Nick is a partner at Oxford Science Enterprises, where he previously served as principal. He also holds board director roles at several companies, including Theolytics, Oxford Quantum Circuits, Natcap, and Circadian Therapeutics.
LinkedInSchoppig Schoppig
Health Tech Investment Principal
Joel Schoppig
Health Tech Investment Principal
Joel brings health tech investment and venture building experience from roles at Oxford Science Enterprises, Pitango, and Healthy.io.
LinkedInThe Series C round was co-led by Oxford Science Enterprises and Supernova Invest to support product development.
"When we helped spin Moa out from the University of Oxford’s Plant Sciences Department in 2017, we saw that its technology platform had a unique and important approach to address the market’s need for herbicides capable of breaking weed resistance,"
Bullhound Capital led the Series C financing, which stands as Europe's largest private quantum funding round.
"Globally, it represents a clear shift in the market from long-term promise to near-term delivery in quantum computing. For OQC, this gives us the capital to scale internationally, advance our technology roadmap, and meet increasing demand from customers seeking secure, scalable access to quantum computing infrastructure."
The funding round was co-led by DCVC and Kembara with participation from the British Business Bank and Firgun.
"Today's announcement reflects the strength of the team we have built and the progress they have delivered. Quantum computing will only achieve its full potential if it can be built on a platform that scales, and we believe silicon is the strongest route to achieving that. We are pleased to be joined by investors who share our vision and understand what it takes to build a foundational company in this field."
The round was led by Santander Alternative Investments to support the commercial rollout of the company optical ground station.
"It is an exciting moment for Archangel Lightworks to be able to announce this successful round of capital as the demand for space-based information and connectivity continues to grow exponentially. The Archangel Lightworks team has done incredible work designing, building, and deploying our laser communications systems, and now is the time for us to accelerate with our partners, new and old, to meet the needs that we are hearing from our customers across markets."
The proposed funding round is reportedly led in part by Accel with backing from the NATO Innovation Fund and Oxford Science Enterprises.
